Literature DB >> 9512000

Member of the peroxisome proliferator-activated receptor family of transcription factors is differentially expressed by oligodendrocytes.

J Granneman1, R Skoff, X Yang.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that form a subfamily within the steroid hormone receptor group. Recent work has shown that one member of this group, PPARgamma, plays a central role in adipocyte differentiation. As oligodendrocytes are major lipid-producing cells, we investigated whether members of the PPAR family were present in oligodendrocytes and whether known PPAR activators affect oligodendrocyte differentiation. Polymerase chain reaction and nuclease protection analyses demonstrated that the principal PPAR present in optic nerve and sciatic nerve is PPARdelta, whereas adipose tissue expresses mainly PPARgamma. In situ hybridization of primary glial cultures revealed PPARdelta message in oligodendrocytes but not in astrocytes. PPARdelta message was strongly expressed in immature oligodendrocytes, suggesting a role in oligodendrocyte differentiation. Glial cultures containing immature oligodendrocytes were treated with CP 68,722 and bromopalmitate, compounds known to activate PPARs in adipocytes. These agents increased the number of oligodendrocytes with membrane sheets three- to fourfold, accelerated the rate of formation of membrane sheets, and increased the size of the membrane sheets. The abundant expression of PPARdelta in oligodendrocytes in vivo and in vitro suggests that this PPAR plays a critical role in oligodendrocyte development and that PPAR activators can be used to manipulate oligodendrocyte maturation in tissue culture.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512000     DOI: 10.1002/(SICI)1097-4547(19980301)51:5<563::AID-JNR3>3.0.CO;2-D

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  19 in total

Review 1.  Oligodendrocyte fate after spinal cord injury.

Authors:  Akshata Almad; F Rezan Sahinkaya; Dana M McTigue
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

Review 2.  Myelin status and oligodendrocyte lineage cells over time after spinal cord injury: What do we know and what still needs to be unwrapped?

Authors:  Nicole Pukos; Matthew T Goodus; Fatma R Sahinkaya; Dana M McTigue
Journal:  Glia       Date:  2019-08-24       Impact factor: 7.452

3.  Long-term n-3 FA deficiency modifies peroxisome proliferator-activated receptor beta mRNA abundance in rat ocular tissues.

Authors:  Cecilia V Rojas; Rebecca S Greiner; Lidia C Fuenzalida; Jessica I Martinez; Norman Salem; Ricardo Uauy
Journal:  Lipids       Date:  2002-04       Impact factor: 1.880

4.  Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor-β.

Authors:  Malabendu Jana; Susanta Mondal; Frank J Gonzalez; Kalipada Pahan
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

5.  Peroxisome proliferator-activated receptor delta agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis.

Authors:  Saravanan Kanakasabai; Wanida Chearwae; Crystal C Walline; Wade Iams; Suzanne M Adams; John J Bright
Journal:  Immunology       Date:  2010-04-06       Impact factor: 7.397

6.  Chronic expression of PPAR-delta by oligodendrocyte lineage cells in the injured rat spinal cord.

Authors:  Akshata Almad; Dana M McTigue
Journal:  J Comp Neurol       Date:  2010-03-15       Impact factor: 3.215

7.  PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors.

Authors:  Elisabetta Benedetti; Renato Galzio; Barbara D'Angelo; Maria Paola Cerù; Annamaria Cimini
Journal:  PPAR Res       Date:  2010-03-17       Impact factor: 4.964

8.  Promoting return of function in multiple sclerosis: An integrated approach.

Authors:  Mar Gacias; Patrizia Casaccia
Journal:  Mult Scler Relat Disord       Date:  2013-10-01       Impact factor: 4.339

9.  Genomic organization of the mouse peroxisome proliferator-activated receptor beta/delta gene: alternative promoter usage and splicing yield transcripts exhibiting differential translational efficiency.

Authors:  Leif K Larsen; Ez-Zoubir Amri; Susanne Mandrup; Corinne Pacot; Karsten Kristiansen
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

10.  Regulation of oligodendrocyte progenitor cell maturation by PPARδ: effects on bone morphogenetic proteins.

Authors:  Maria Vittoria Simonini; Paul E Polak; Anne I Boullerne; Jeffrey M Peters; Jill C Richardson; Douglas L Feinstein
Journal:  ASN Neuro       Date:  2010-01-15       Impact factor: 5.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.